EXPERIMENTAL AND MOLECULAR MEDICINE（实验与分子医学杂志）影响因子_期刊投稿发表

期刊简介

Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal.Topics of particular interest within the journal's scope include, but are not limited to, those listed below:Cancer biologyImmunologyNeuroscienceCardiovascular biologyGenetics and genomicsGene therapyMetabolic diseasesStem cells and regenerative medicinePhysiology and diseasesMolecular Medicine.

《实验与分子医学》（Experimental & Molecular Medicine，简称EMM）是韩国第一本生物化学期刊（创办于1964年），于1996年作为开放获取、完全同行评审的国际期刊重新发行。它是一本医学研究杂志，致力于发表转化研究的最新进展和生物医学领域的最新发现。鼓励投稿涉及人类生理和疾病的遗传、分子和细胞研究的论文。该杂志旨在强调使用特定分子工具进行的实验和转化研究对人类健康的临床益处。包含具有临床相关性的基本发现的研究以及涉及明确的体内相关性和新奇性的文章也将受到欢迎。《实验与分子医学》是一本开放获取、仅限在线的期刊。该期刊范围内的特别感兴趣的主题包括但不限于下列主题：癌症生物学免疫学神经科学心血管生物学遗传学和基因组学基因治疗代谢性疾病干细胞和再生医学生理学和疾病分子医学。

《EXPERIMENTAL AND MOLECULAR MEDICINE》期刊已被查看：次

分区信息